15 results
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
results or prospects.
(ll) Cybersecurity. (i)(x) There has been no security breach or other compromise of or relating to any of the Company’s or any
8-K
EX-10.1
VBIVQ
VBI Vaccines Inc
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
or prospects.
(jj) Cybersecurity. (i)(x) There has been no security breach or other compromise of or relating to any of the Company’s or any Subsidiary’s
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
reasonably be expected to result in such exclusion, suspension or debarment.
(gg) Cybersecurity. The Company and its Subsidiaries’ information technology
8-K
EX-1.1
3sui71g3vz89
3 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
z6vlc75u
7 Dec 20
VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine
10:23am
S-3ASR
EX-1.2
njsw5x32
31 Jul 20
Automatic shelf registration
4:58pm
- Prev
- 1
- Next